Synflorix

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

PneumoniaPneumococcal Infection

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

1

Synflorix

GSK

Phase 3

12

Primaxin

Pfizer

Preclinical

23

Innohep

Alnylam Pharmaceuticals

Preclinical

14

Acanya

Pfizer

Preclinical

15

Primaquine

Sanofi

Preclinical

16

Prevacid

Takeda

Preclinical

17

Jakafi

Incyte

Preclinical

18

Avlosulfon

AAlmirall, S.A.

Preclinical

49

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

1210

Gantanol

CConrado Roberto Hoffmann Filho

Preclinical

2Show 34 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immunogenicity10 trials

Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

Completed·GSK·Phase 2·NCT00513409·163 enrolled

Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

Completed·GSK·Phase 2·NCT01262872·1,320 enrolled

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Completed·GSK·Phase 3·NCT00370396·1,200 enrolled

Show 7 more trials

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

Completed·GSK·Phase 2·NCT01616459·953 enrolled

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Completed·GSK·Phase 3·NCT01309646·454 enrolled

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Completed·GSK·Phase 2·NCT01171989·391 enrolled

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

Completed·GSK·Phase 2·NCT01204658·576 enrolled

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Completed·GSK·Phase 3·NCT00345358·600 enrolled

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

Completed·GSK·Phase 1·NCT01485406·61 enrolled

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

Completed·GSK·Phase 3·NCT01144663·2,095 enrolled

Vaccination5 trials

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

Withdrawn·PPublic Health England·Phase 4·NCT02918708

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Completed·GSK·Phase 3·NCT00533507·230 enrolled

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Completed·GSK·Phase 3·NCT00489554·230 enrolled

Show 2 more trials

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

Completed·GSK·Phase 3·NCT01153841·300 enrolled

Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Completed·GSK·Phase 3·NCT01641133·457 enrolled

Vaccine4 trials

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

Withdrawn·GSK·Phase 2·NCT01110044

Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

Terminated·GSK··NCT01046097·28 enrolled

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

Completed·PPATH·Phase 3·NCT03197376·2,250 enrolled

Show 1 more trial

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Completed·PPATH·Phase 3·NCT03896477·660 enrolled

Pneumococcal Vaccines2 trials

Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life

Completed·MMenzies School of Health Research·Phase 4·NCT01735084·261 enrolled

Pneumococcal Vaccines Early and in Combination

Completed·MMenzies School of Health Research·Phase 4·NCT01174849·425 enrolled

Children1 trial

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

Completed·GSK·Phase 3·NCT00547248·756 enrolled

2 more indications

Pneumonia1 trial

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers

Completed·PPATH·Phase 1/2·NCT02097472·304 enrolled

Pneumococcal Infection1 trial

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection

Completed·GSK·Phase 3·NCT01746108·52 enrolled

Details

Drug Info

Related News